Heather R. Johnson

To learn more about the impact of depression therapy on anxiety symptoms, researchers conducted a randomized controlled clinical trial with teenagers to compare the results of personalized depression therapy to a program that does not match their risk factors.

Using a shortened Nature Relatedness Scale, the Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS), and sociodemographic information, the researchers surveyed 386 individuals aged 18 to 65 about their feelings of connection to nature and mental well-being.

Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.

The researchers recruited participants from the Depression Evaluation Longitudinal Therapy Assessment (DELTA)-study and other methods. They recruited 73 patients with major depressive disorder and 45 controls.

As households worldwide sheltered in place during the start of the COVID-19 pandemic, children aged 12 experienced a range of sleep disturbances. Researchers of this study conducted a systematic review of these issues.

Investigators examined the incidence and severity of newly diagnosed anorexia nervosa and atypical anorexia nervosa in Canada before and during the COVID-19 pandemic.

Investigators conducted a meta-analysis to assess perturbations in gut microbiota among patients with psychiatric disorders.

A Danish study compared the rate of new-onset mental disorders among people diagnosed with Lyme disease vs the rate in people without Lyme disease.

The study authors explored the odds of significant COVID-19 morbidity and mortality among schizophrenia patients while controlling for potential sociodemographic and medical confounders.

With COVID-19 having truly disastrous effects, the study authors sought to uncover the toll of substance abuse during the pandemic.